{
    "SLCO1B3": {
        "expression": [
            {
                "Organ": "Kidney",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 0.0689
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 8.511
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "17beta-estradiol",
                "IC50 (μM)": 12.9,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Inhibitor": "Amprenavir",
                "IC50 (μM)": 19.1,
                "Ki (μM)": 13.1,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Antamanide",
                "IC50 (μM)": 0.7,
                "Ki (μM)": 0.7,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Antamanide",
                "IC50 (μM)": 15.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Atazanavir",
                "IC50 (μM)": 3.0,
                "Ki (μM)": 2.0,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Bromsulphthalein (BSP)",
                "IC50 (μM)": 3.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Bromsulphthalein (BSP)",
                "IC50 (μM)": 1.4,
                "Ki (μM)": 1.0,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Cholecystokinin 8",
                "IC50 (μM)": 10.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Cyclosporine*",
                "IC50 (μM)": 0.3,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Cyclosporine*",
                "IC50 (μM)": 0.8,
                "Ki (μM)": null,
                "Substrate used": "Bosentan",
                "Cell System": "CHO-OATP1B1",
                "Reference": "Treiber, 2007"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": 0.3,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Cyclosporine*",
                "IC50 (μM)": 0.06,
                "Ki (μM)": null,
                "Substrate used": "Rosuvastatin",
                "Cell System": "HeLa-OATP1B3",
                "Reference": "Ho, 2006"
            },
            {
                "Inhibitor": "Darunavir",
                "IC50 (μM)": 4.8,
                "Ki (μM)": 3.3,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Digoxin",
                "IC50 (μM)": 1.0,
                "Ki (μM)": 0.7,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Estrone 3-sulfate",
                "IC50 (μM)": 97.1,
                "Ki (μM)": null,
                "Substrate used": "Cholecystokinin 8",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Ishiguro, 2006"
            },
            {
                "Inhibitor": "Fexofenadine",
                "IC50 (μM)": null,
                "Ki (μM)": 205.0,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Shimizu, 2005"
            },
            {
                "Inhibitor": "Indinavir",
                "IC50 (μM)": 12.3,
                "Ki (μM)": 8.5,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Lithocholate",
                "IC50 (μM)": 6.8,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Inhibitor": "Lopinavir*",
                "IC50 (μM)": 2.0,
                "Ki (μM)": 1.4,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Mifepristone",
                "IC50 (μM)": 5.3,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 0.5,
                "Ki (μM)": 0.2,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": 0.3,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Montelukast",
                "IC50 (μM)": 15.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Montelukast",
                "IC50 (μM)": 0.5,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Paclitaxel",
                "IC50 (μM)": 2.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Paclitaxel",
                "IC50 (μM)": 4.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Paclitaxel",
                "IC50 (μM)": 0.5,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Inhibitor": "Penicillin G",
                "IC50 (μM)": 25.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Prednisolone phosphate",
                "IC50 (μM)": 75.0,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": null,
                "Ki (μM)": 130.0,
                "Substrate used": "Fexofenadine",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Tahara, 2006"
            },
            {
                "Inhibitor": "Repaglinide",
                "IC50 (μM)": 5.6,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Bachmakov, 2008"
            },
            {
                "Inhibitor": "Rifampicin",
                "IC50 (μM)": 0.8,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Rifampicin*",
                "IC50 (μM)": 1.6,
                "Ki (μM)": null,
                "Substrate used": "Bosentan",
                "Cell System": "CHO-OATP1B1",
                "Reference": "Treiber, 2007"
            },
            {
                "Inhibitor": "Rifampicin",
                "IC50 (μM)": 1.5,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Rifampicin*",
                "IC50 (μM)": null,
                "Ki (μM)": 5.0,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Inhibitor": "Rifampicin*",
                "IC50 (μM)": 1.3,
                "Ki (μM)": 0.9,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Rifampicin*",
                "IC50 (μM)": 2.6,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Inhibitor": "Rifamycin SV",
                "IC50 (μM)": null,
                "Ki (μM)": 3.0,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Inhibitor": "Ritonavir",
                "IC50 (μM)": 3.6,
                "Ki (μM)": 2.5,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Rosiglitazone",
                "IC50 (μM)": 10.9,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Bachmakov, 2008"
            },
            {
                "Inhibitor": "Saquinavir",
                "IC50 (μM)": 4.1,
                "Ki (μM)": 2.8,
                "Substrate used": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Inhibitor": "Sildenafil",
                "IC50 (μM)": 4.0,
                "Ki (μM)": null,
                "Substrate used": "Bosentan",
                "Cell System": "CHO-OATP1B1",
                "Reference": "Treiber, 2007"
            },
            {
                "Inhibitor": "Silibinin dihemisuccinate",
                "IC50 (μM)": 0.4,
                "Ki (μM)": null,
                "Substrate used": "Amantinin",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Silibinin dihemisuccinate",
                "IC50 (μM)": 1.0,
                "Ki (μM)": null,
                "Substrate used": "Bromsulphthalein (BSP)",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Inhibitor": "Troglitazone",
                "IC50 (μM)": 15.7,
                "Ki (μM)": null,
                "Substrate used": "Estradiol-17beta-glucuronide",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            }
        ],
        "substrates": [
            {
                "Substrate": "17beta-Glucuronosyl estradiol",
                "Km (μM)": "5.4",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Cui, 2001"
            },
            {
                "Substrate": "Amantinin",
                "Km (μM)": "3.7",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Letschert, 2006"
            },
            {
                "Substrate": "Bilirubin",
                "Km (μM)": "0.0391",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Briz, 2003"
            },
            {
                "Substrate": "Bosentan",
                "Km (μM)": "141",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Treiber, 2007"
            },
            {
                "Substrate": "Bromsulphthalein (BSP)",
                "Km (μM)": "0.4",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Bromsulphthalein (BSP)",
                "Km (μM)": "3.3",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Cui, 2001"
            },
            {
                "Substrate": "Cholecystokinin 8",
                "Km (μM)": "3.82",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Hirano, 2004"
            },
            {
                "Substrate": "Cholecystokinin 8",
                "Km (μM)": "16.5",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Poirier, 2009"
            },
            {
                "Substrate": "Cholyl-glycylamido-fluorescein (CGamF)",
                "Km (μM)": "2.2",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Annaert, 2010"
            },
            {
                "Substrate": "Digoxin",
                "Km (μM)": "ND",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Kullak-Ublick, 2001"
            },
            {
                "Substrate": "Estradiol-17beta-glucuronide",
                "Km (μM)": "15.8",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Substrate": "Estradiol-17beta-glucuronide",
                "Km (μM)": "24.6",
                "Cell System": "HEK293-OATP1B1",
                "Reference": "Hirano, 2004"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "58",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Substrate": "Fexofenadine",
                "Km (μM)": "108",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Shimizu, 2005"
            },
            {
                "Substrate": "Fluo-3",
                "Km (μM)": "3.1",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Gui, 2008"
            },
            {
                "Substrate": "Fluvastatin*",
                "Km (μM)": "7",
                "Cell System": "MDCK II-OATP1B3",
                "Reference": "Kopplow, 2005"
            },
            {
                "Substrate": "Glycoursodeoxycholate",
                "Km (μM)": "24.7",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Maeda, 2006"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "24.7",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Abe, 2001"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "39.4",
                "Cell System": "MDCK-OATP1B3",
                "Reference": "Abe, 2001"
            },
            {
                "Substrate": "Monoglucuronosyl bilirubin",
                "Km (μM)": "0.5",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Cui, 2001"
            },
            {
                "Substrate": "Olmesartan",
                "Km (μM)": "44.2",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Yamada, 2007"
            },
            {
                "Substrate": "Olmesartan",
                "Km (μM)": "71.8",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Nakagomi-Hagihara, 2006"
            },
            {
                "Substrate": "Paclitaxel",
                "Km (μM)": "6.79",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Smith, 2005"
            },
            {
                "Substrate": "Pitavastatin*",
                "Km (μM)": "3.25",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Hirano, 2004"
            },
            {
                "Substrate": "Pitavastatin*",
                "Km (μM)": "3.8",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Fujino, 2005"
            },
            {
                "Substrate": "Rifampicin",
                "Km (μM)": "2.3",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Vavricka, 2002"
            },
            {
                "Substrate": "Rosuvastatin*",
                "Km (μM)": "9.8",
                "Cell System": "HeLa-OATP1B3",
                "Reference": "Ho, 2006"
            },
            {
                "Substrate": "Rosuvastatin*",
                "Km (μM)": "14.2",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Kitamura, 2008"
            },
            {
                "Substrate": "Taurocholate",
                "Km (μM)": "5.8",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Abe, 2001"
            },
            {
                "Substrate": "Tauroursodeoxycholate",
                "Km (μM)": "15.9",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Maeda, 2006"
            },
            {
                "Substrate": "Telmisartan*",
                "Km (μM)": "0.81",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Ishiguro, 2006"
            },
            {
                "Substrate": "Telmisartan",
                "Km (μM)": "0.81",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Ishiguro, 2006"
            },
            {
                "Substrate": "Telmisartan glucuronide",
                "Km (μM)": "3.4",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Ishiguro, 2008"
            },
            {
                "Substrate": "Triiodothyronine",
                "Km (μM)": "6.4",
                "Cell System": "OATP1B3-expressing oocytes",
                "Reference": "Abe, 2001"
            },
            {
                "Substrate": "Valsartan",
                "Km (μM)": "18.2",
                "Cell System": "HEK293-OATP1B3",
                "Reference": "Yamashiro, 2006"
            },
            {
                "Substrate": "Valsartan",
                "Km (μM)": "23.5",
                "Cell System": "CHO-OATP1B3",
                "Reference": "Poirier, 2009"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Atazanavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "3.1",
                "Cmax": "7.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Busti, 2008",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Docetaxel",
                "AUC": "7.3",
                "Cmax": "5.7",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Malingre, 2001",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Paclitaxel",
                "AUC": "8.5",
                "Cmax": "2.0",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Meerum, 1999",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Pitavastatin",
                "AUC": "4.6",
                "Cmax": "6.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Livalo Drug Label",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "5.0",
                "Cmax": "10.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "ABCG2/OATPs",
                "Interacting Drug": "Cyclosporine",
                "Affected Drug": "Rosuvastatin",
                "AUC": "6.4",
                "Cmax": "18.2",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Simonson, 2004",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Erythromycin",
                "Affected Drug": "Simvastatin",
                "AUC": "6.2",
                "Cmax": "3.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Indinavir  / Ritonavir",
                "Affected Drug": "Fexofenadine",
                "AUC": "4.8",
                "Cmax": "2.5",
                "CLR": "ND",
                "CL/F": "0.2",
                "t1/2": "0.7",
                "Effect on PD": "ND",
                "Reference": "Kharasch, 2009",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Lopinavir  / Ritonavir",
                "Affected Drug": "Rosuvastatin",
                "AUC": "2.1",
                "Cmax": "4.7",
                "CLR": "ND",
                "CL/F": "0.5",
                "t1/2": "NS",
                "Effect on PD": "yes",
                "Reference": "Kiser, 2008",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATPs",
                "Interacting Drug": "Rifampicin",
                "Affected Drug": "Glyburide",
                "AUC": "2.2",
                "Cmax": "1.8",
                "CLR": "NS",
                "CL/F": "0.5",
                "t1/2": "ND",
                "Effect on PD": "yes",
                "Reference": "Zheng, 2009",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Digoxin",
                "AUC": "1.9",
                "Cmax": "ND",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "2.6",
                "Effect on PD": "ND",
                "Reference": "Ding, 2004",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Ritonavir",
                "Affected Drug": "Saquinavir",
                "AUC": "29.9",
                "Cmax": "22.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "la, 2007",
                "More Details": "DDI 12"
            },
            {
                "DDI": "13",
                "Implicated Transporter": "ABCB1/OATPs",
                "Interacting Drug": "Verapamil",
                "Affected Drug": "Simvastatin",
                "AUC": "4.6",
                "Cmax": "2.6",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Kantola, 1998",
                "More Details": "DDI 13"
            }
        ]
    }
}